Gracell Biotechnologies Revenue

Biotechnology Research • Gusu District, Jiangsu, China • 21-50 Employees

Gracell Biotechnologies revenue & valuation

Annual revenue	$57,000
Revenue per employee	$2,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$182,400
Total funding	$100,000,000

Key Contacts at Gracell Biotechnologies

Wenjie Yin

Senior Research Director

Tao Zhang

Director, Business Development

Sophia Ng

Sr. Legal Director

Wenhui Huang

Director Of Bioinformatics

Jing Jiao

Director

Corrine Chen

Director Of Hr

华张

Rd Director

Ping Xu

Preclinical Development Director

Company overview

Headquarters	Gusu District, Jiangsu, China
Phone number	+862164031375
Website	gracellbio.com
NAICS	541714
SIC	873
Keywords	Car-T And Cell Therapy
Founded	2017
Employees	21-50
Socials

Gracell Biotechnologies Email Formats

Gracell Biotechnologies uses 1 email format. The most common is {first name}_{last name} (e.g., john_doe@gracellbio.com), used 100% of the time.

Format	Example	Percentage
{first name}_{last name}	john_doe@gracellbio.com	100%

About Gracell Biotechnologies

As a member of the AstraZeneca Group, Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing novel autologous and allogeneic cell therapies for cancer and autoimmune diseases. Since its inception, Gracell has established a solid inhouse R&D system. Leveraging its proprietary FasTCAR and TruUCAR technology platforms and SMART CART™ technology modules, Gracell is researching new ways to address current challenges with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal T cell quality and barriers that limit their activity in solid tumors and autoimmune diseases.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

Director

Employees by Department

Gracell Biotechnologies has 16 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Gracell Biotechnologies's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-09-07	14	$100,000,000

Funding Insights

$100,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Gracell Biotechnologies Tech Stack

Discover the technologies and tools that power Gracell Biotechnologies's digital infrastructure, from frameworks to analytics platforms.

Hugo

Static site generator

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

HSTS

Security

Hammer.js

JavaScript libraries

Bootstrap

UI frameworks

Flickity

JavaScript libraries

Frequently asked questions

Gracell Biotechnologies is located in Gusu District, Jiangsu, CN.

You can reach Gracell Biotechnologies at +862164031375.

Gracell Biotechnologies generates an estimated annual revenue of $57,000. This revenue figure reflects the company's market position and business performance in its industry.

Gracell Biotechnologies has an estimated valuation of $182,400. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Gracell Biotechnologies was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Gracell Biotechnologies has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Gracell Biotechnologies has raised a total of $100,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Gracell Biotechnologies

Wenjie Yin

Senior Research Director

Tao Zhang

Director, Business Development

Sophia Ng

Sr. Legal Director

Wenhui Huang

Director Of Bioinformatics

Jing Jiao

Director

Corrine Chen